Highly innovative drugs in the Czech Republic: retrospective analysis of impact on early market entry, regular reimbursement system entry and public pharmaceutical expenditure
نویسندگان
چکیده
Objectives This study aims to describe a specific system of reimbursement of highly innovative drugs (HID) in the Czech Republic, representing a time-limited reimbursement under special conditions. The second objective is to evaluate the total number of drugs approved as HID, as well as the number of drugs entering or failing to enter the system of regular reimbursement. The third objective is to describe the development of costs and impact of HID on the overall public pharmaceutical expenditures.
منابع مشابه
The impact of children’s entry to labor market on health expenditures of urban household
Child labor is regarded as an ambiguous and controversial challenge encountered in majority of countries across the world. Given the incidence and prevalence of this phenomenon in Iran and the importance of household health expenditures, this study was done to evaluate the impact of children’s entry into labor market on household health expenditures. This study was conducted on urban households...
متن کاملHealth Technology Assessment in Evaluation of Pharmaceuticals in the Czech Republic.
OBJECTIVES In the Czech Republic, the health technology assessment (HTA) approaches have been implemented in evaluation of medicinal products since 2008. The aim of this study was to provide an overview of the implementation of HTA and different levels thereof in the evaluation process conducted by the State Institute for Drug Control (SUKL) and to describe the impact of HTA on the entrance of ...
متن کاملExpensive medicines: ensuring objective appraisal and equitable access
Editorials 4 In response to requests for the funding of new drugs, reimbursement agencies are re-evaluating some of the methods used in assessing these products. Many trials submitted for the regulatory review of new drugs do not provide adequate data for subsidy decisions. We argue that all involved in bringing medicines to market need to be explicit about the additional information required, ...
متن کاملPricing and Reimbursement of Biosimilars in Central and Eastern European Countries
Objectives: The aim of this study was to review the requirements for the reimbursement of biosimilars and to compare the reimbursement status, market share, and reimbursement costs of biosimilars in selected Central and Eastern European (CEE) countries. Methods: A questionnaire-based survey was conducted between November 2016 and January 2017 among experts from the following CEE countries: Bulg...
متن کاملPharmaceutical expenditure forecast model to support health policy decision making
BACKGROUND AND OBJECTIVE With constant incentives for healthcare payers to contain their pharmaceutical budgets, modelling policy decision impact became critical. The objective of this project was to test the impact of various policy decisions on pharmaceutical budget (developed for the European Commission for the project 'European Union (EU) Pharmaceutical expenditure forecast' - http://ec.eur...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 8 شماره
صفحات -
تاریخ انتشار 2015